31146332|t|(E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates MPTP-Induced Dopaminergic Neurodegeneration by Inhibiting the STAT3 Pathway.
31146332|a|Neuroinflammation is implicated in dopaminergic neurodegeneration. We have previously demonstrated that (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol (MMPP), a selective signal transducer and activator of transcription 3 (STAT3) inhibitor, has anti-inflammatory properties in several inflammatory disease models. We investigated whether MMPP could protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic cell loss and behavioral impairment. Imprinting control region (ICR) mice (8 weeks old, n = 10 per group) were administered MMPP (5 mg/kg) in drinking water for 1 month, and injected with MPTP (15 mg/kg, four times with 2 h intervals) during the last 7 days of treatment. MMPP decreased MPTP-induced behavioral impairments in rotarod, pole, and gait tests. We also showed that MMPP ameliorated dopamine depletion in the striatum and inflammatory marker elevation in primary cultured neurons by high-performance liquid chromatography and immunohistochemical analysis. Increased activation of STAT3, p38, and monoamine oxidase B (MAO-B) were observed in the substantia nigra and striatum after MPTP injection, effects that were attenuated by MMPP treatment. Furthermore, MMPP inhibited STAT3 activity and expression of neuroinflammatory proteins, including ionized calcium binding adaptor molecule 1 (Iba1), inducible nitric oxide synthase (iNOS), and glial fibrillary acidic protein (GFAP) in 1-methyl-4-phenylpyridinium (MPP+; 0.5 mM)-treated primary cultured cells. However, mitogen-activated protein kinase (MAPK) inhibitors augmented the activity of MMPP. Collectively, our results suggest that MMPP may be an anti-inflammatory agent that attenuates dopaminergic neurodegeneration and neuroinflammation through MAO-B and MAPK pathway-dependent inhibition of STAT3 activation.
31146332	0	59	(E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol	Chemical	-
31146332	72	76	MPTP	Chemical	-
31146332	85	115	Dopaminergic Neurodegeneration	Disease	MESH:D009422
31146332	134	139	STAT3	Gene	20848
31146332	149	166	Neuroinflammation	Disease	MESH:D000090862
31146332	184	214	dopaminergic neurodegeneration	Disease	MESH:D009422
31146332	253	312	(E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol	Chemical	-
31146332	314	318	MMPP	Chemical	MESH:C044731
31146332	333	383	signal transducer and activator of transcription 3	Gene	20848
31146332	385	390	STAT3	Gene	20848
31146332	412	424	inflammatory	Disease	MESH:D007249
31146332	447	467	inflammatory disease	Disease	MESH:D007249
31146332	500	504	MMPP	Chemical	MESH:C044731
31146332	527	571	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chemical	MESH:D015632
31146332	573	577	MPTP	Chemical	-
31146332	587	609	dopaminergic cell loss	Disease	MESH:D002292
31146332	614	635	behavioral impairment	Disease	MESH:D001523
31146332	669	673	mice	Species	10090
31146332	724	728	MMPP	Chemical	MESH:C044731
31146332	788	792	MPTP	Chemical	-
31146332	872	876	MMPP	Chemical	MESH:C044731
31146332	887	891	MPTP	Chemical	-
31146332	900	922	behavioral impairments	Disease	MESH:D001523
31146332	977	981	MMPP	Chemical	MESH:C044731
31146332	994	1002	dopamine	Chemical	MESH:D004298
31146332	1033	1045	inflammatory	Disease	MESH:D007249
31146332	1191	1196	STAT3	Gene	20848
31146332	1198	1201	p38	Gene	26416
31146332	1207	1226	monoamine oxidase B	Gene	109731
31146332	1228	1233	MAO-B	Gene	109731
31146332	1292	1296	MPTP	Chemical	-
31146332	1340	1344	MMPP	Chemical	MESH:C044731
31146332	1369	1373	MMPP	Chemical	MESH:C044731
31146332	1384	1389	STAT3	Gene	20848
31146332	1506	1537	inducible nitric oxide synthase	Gene	18126
31146332	1539	1543	iNOS	Gene	18126
31146332	1550	1581	glial fibrillary acidic protein	Gene	14580
31146332	1583	1587	GFAP	Gene	14580
31146332	1592	1619	1-methyl-4-phenylpyridinium	Chemical	MESH:D015655
31146332	1753	1757	MMPP	Chemical	MESH:C044731
31146332	1798	1802	MMPP	Chemical	MESH:C044731
31146332	1818	1830	inflammatory	Disease	MESH:D007249
31146332	1853	1883	dopaminergic neurodegeneration	Disease	MESH:D009422
31146332	1888	1905	neuroinflammation	Disease	MESH:D000090862
31146332	1914	1919	MAO-B	Gene	109731
31146332	1961	1966	STAT3	Gene	20848
31146332	Negative_Correlation	MESH:C044731	MESH:D007249
31146332	Association	MESH:D007249	20848
31146332	Negative_Correlation	MESH:C044731	18126
31146332	Positive_Correlation	MESH:D015632	MESH:D002292
31146332	Positive_Correlation	MESH:D015632	MESH:D001523
31146332	Association	MESH:D009422	109731
31146332	Association	MESH:D009422	20848
31146332	Negative_Correlation	MESH:C044731	MESH:D015655
31146332	Negative_Correlation	MESH:C044731	109731
31146332	Negative_Correlation	MESH:C044731	20848
31146332	Negative_Correlation	MESH:C044731	MESH:D002292
31146332	Negative_Correlation	MESH:C044731	14580
31146332	Negative_Correlation	MESH:C044731	26416
31146332	Negative_Correlation	MESH:C044731	MESH:D001523
31146332	Negative_Correlation	MESH:C044731	MESH:D004298
31146332	Association	MESH:C044731	MESH:D015632
31146332	Association	MESH:D000090862	109731

